Abstract
As Covid-19 vaccines are being distributed throughout the nation, there has been increased concern regarding the deferral period for blood donation. There are no uniform deferral criteria across the globe till date and the deferral period in some countries depend upon the type of Covid-19 vaccine being administered. Deferral period post-vaccination has impacted on the number of eligible blood donors available to donate blood which can eventually result in shortage of blood and blood components. An imbalance between the availability and demand of blood supplies can ultimately lead to adverse outcomes in the health care system. Hence, it is imperative to promote autologous blood donation programmes to attain an active patient blood management strategy nationwide so as to reduce the impact of allogenic blood shortage and risks of allogenic blood transfusion.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
